Back to Results
First PageMeta Content
Health / Malaria / Vaccination / Vaccines / Virus-like particle / Biotechnology / Malaria vaccine / Medicine / Biology / Microbiology


A vaccine against placental malaria made with ExpreS2ion Biotechnologies’ protein expression technology, ExpreS2, is ready to start human tests in Germany and Benin Hørsholm, Denmark, 20th March 2015 – Biotech Compa
Add to Reading List

Document Date: 2015-03-20 09:16:18

Open Document

File Size: 283,49 KB

Share Result on Facebook

City

Benin Hørsholm / /

Company

Biotech Company / Biotechnologies / /

Country

Germany / Denmark / /

/

Facility

University of Copenhagen / /

IndustryTerm

protein expression technology / biopharmaceutical industry / protein manufacturing / process development services / manufacturing processes / /

MedicalCondition

HIV infection / malaria / Placental Malaria Placental malaria / notoriously challenging malaria / malaria infection / complex malaria / placental malaria / /

Organization

Danish Advanced Technology Foundation / Department of Immunology and Microbiology / World Health Organization / European Union / University of Copenhagen / Innovation Fund / /

Person

Ali Salanti / Charlotte Dyring / Sancha Salgueiro / /

/

Position

CEO / Professor / /

Product

ExpreS2 / /

Technology

recombinant protein production / protein expression technology / /

URL

www.expres2ionbio.com / /

SocialTag